BIOLOGICAL E LIMITED
HYDERABAD, Telangana, India
Purpose
To support expansion of manufacturing for the accelerated production of nOPV2 to enable the rapid substitution of nOPV2 for mOPV2 to ensure vaccine supply to at risk infant populations in low income countries.
Division
Global Health
Date
February 2024
Region Served
GLOBAL
Committed amount
$2,924,450
Grant topic
Vaccine Development
Duration (months)
12
Grantee location
HYDERABAD, Telangana, India
Related work
More about our financials
Our story
Learn about the origins of the foundation and the values that drive our work.
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.